Molecular Cancer Therapeutics (MCT) publishes translational research studies focused on the discovery and preclinical development of therapeutic agents for oncology. In appreciation, all CICR members who publish in MCT receive a special discount of 5% on the publication charges (excluding the open access fee) in addition to the AACR member discount of 10%. Use the code CICRAO when receiving notification from the MCT staff about author billing. Visit the MCT website to view recent issues and learn how you can submit manuscripts for consideration on our Information for Authors page.